Literature DB >> 34372556

Antiviral Activity of Chrysin against Influenza Virus Replication via Inhibition of Autophagy.

Seong-Ryeol Kim1, Myeong-Seon Jeong2, Seo-Hyeon Mun1, Jaewon Cho1, Min-Duk Seo3, Hyoungsu Kim3, Jooeun Lee2, Jae-Hyoung Song1,4, Hyun-Jeong Ko1.   

Abstract

Influenza viruses cause respiratory infections in humans and animals, which have high morbidity and mortality rates. Although several drugs that inhibit viral neuraminidase are used to treat influenza infections, the emergence of resistant viruses necessitates the urgent development of new antiviral drugs. Chrysin (5,7-dihydroxyflavone) is a natural flavonoid that exhibits antiviral activity against enterovirus 71 (EV71) by inhibiting viral 3C protease activity. In this study, we evaluated the antiviral activity of chrysin against influenza A/Puerto Rico/8/34 (A/PR/8). Chrysin significantly inhibited A/PR/8-mediated cell death and the replication of A/PR/8 at concentrations up to 2 μM. Viral hemagglutinin expression was also markedly decreased by the chrysin treatment in A/PR/8-infected cells. Through the time course experiment and time-of-addition assay, we found that chrysin inhibited viral infection at the early stages of the replication cycle. Additionally, the nucleoprotein expression of A/PR/8 in A549 cells was reduced upon treatment with chrysin. Regarding the mechanism of action, we found that chrysin inhibited autophagy activation by increasing the phosphorylation of mammalian target of rapamycin (mTOR). We also confirmed a decrease in LC3B expression and LC3-positive puncta levels in A/PR/8-infected cells. These results suggest that chrysin exhibits antiviral activity by activating mTOR and inhibiting autophagy to inhibit the replication of A/PR/8 in the early stages of infection.

Entities:  

Keywords:  antiviral activity; autophagy; chrysin; influenza A/Puerto Rico/8/34; mTOR

Year:  2021        PMID: 34372556     DOI: 10.3390/v13071350

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  3 in total

Review 1.  Therapeutic benefits of Salvia species: A focus on cancer and viral infection.

Authors:  Chinonso Anthony Ezema; Timothy Prince Chidike Ezeorba; Rita Ngozi Aguchem; Innocent Uzochukwu Okagu
Journal:  Heliyon       Date:  2022-01-13

2.  Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion.

Authors:  Yijing Xin; Shubing Chen; Ke Tang; You Wu; Ying Guo
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

3.  Chrysin Ameliorates Influenza Virus Infection in the Upper Airways by Repressing Virus-Induced Cell Cycle Arrest and Mitochondria-Dependent Apoptosis.

Authors:  Ying Liu; Xun Song; Chenyang Li; Hao Hu; Wanlin Li; Lu Wang; Jing Hu; Chenghui Liao; Hanbai Liang; Zhendan He; Liang Ye
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.